⏳ Fetching live dividend data...
Home › Calculator › ME Dividend Calculator 2026
23andMe Holding Co. · NASDAQ
Price: $0.61 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ME → $71642602532569224.00M in 10 years · $5,968,449,948,415,409,000,000.00/month
23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected via their proprietary kit. These reports offer insights into customers' genetic ancestral origins, predispositions to certain personal health risks, the likelihood of being a carrier for rare conditions that could be passed to offspring, and how their genetic makeup might influence responses to various medications. The Therapeutics segment is dedicated to pharmaceutical research and development, focusing on the discovery and advancement of novel treatments aimed at improving patient well-being across diverse medical fields, including oncology, respiratory, and cardiovascular diseases. This segment also engages in the out-licensing of intellectual property associated with identified drug targets that are progressing through clinical development. 23andMe maintains a strategic partnership with GlaxoSmithKline Intellectual Property (No.3) Limited, leveraging genetic insights to validate, develop, and ultimately commercialize new pharmaceutical products. Established in 2006, the company's corporate headquarters are situated in South San Francisco, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ME position with:
Real after-tax yield depends on where you live and how you hold ME.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 329.87% | 327.07% | $32,987 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 280.39% | 277.59% | $28,039 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 263.90% | 261.10% | $26,390 / yr |
| 🇬🇧 UK ISA | 0% | 329.87% | 327.07% | $32,987 / yr |
| 🇬🇧 UK Taxable | 8.75% | 301.01% | 298.21% | $30,101 / yr |
| 🇨🇦 TFSA | 0% | 329.87% | 327.07% | $32,987 / yr |
| 🇨🇦 CA Taxable | 25% | 247.40% | 244.60% | $24,740 / yr |
| 🇦🇺 Super (pension) | 15% | 280.39% | 277.59% | $28,039 / yr |
| 🇦🇺 AU Taxable | 30% | 230.91% | 228.11% | $23,091 / yr |
| 🇩🇪 DE Taxable | 26.375% | 242.87% | 240.07% | $24,287 / yr |
| 🇫🇷 FR Taxable | 30% | 230.91% | 228.11% | $23,091 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ME pays quarterly — 4 times per year. Next ex-div: TBD.
How ME compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ME sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2025-02-20 | 5,654 | $2.74 | $15.5K | ||
| F-InKind | 2024-11-20 | 5,279 | $3.15 | $16.6K | ||
| A-Award | 2024-08-26 | 658,485 | — | — | ||
| A-Award | 2024-08-26 | 194,552 | $0.33 | $65.0K | ||
| A-Award | 2024-08-26 | 658,485 | — | — | ||
| A-Award | 2024-08-26 | 658,485 | — | — | ||
| A-Award | 2024-08-26 | 202,035 | $0.33 | $67.5K | ||
| A-Award | 2024-08-26 | 658,485 | — | — | ||
| A-Award | 2024-08-26 | 658,485 | — | — | ||
| A-Award | 2024-08-26 | 179,586 | $0.33 | $60.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ME dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
23andMe Holding Co. (ME) is currently trading at $0.61, trading near its 52-week low. The current dividend yield is 329.87% based on an annual payout of $2.00 per share.
23andMe Holding Co. (ME) is a healthcare stock currently trading at $0.61 with a dividend yield of 329.87%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever